Menu

Blog

Archive for the ‘biotech/medical’ category: Page 820

Oct 18, 2022

Scientists Solve an Origin of Life Mystery

Posted by in categories: biotech/medical, chemistry

Researchers from the Universities of Cambridge and Cape Town may have found a solution to the mystery of how phosphorus came to be an essential component of life on Earth by recreating prehistoric seawater containing the element in a laboratory.

Their findings, which were published in the journal Nature Communications.

Nature Communications is a peer-reviewed, open access, multidisciplinary, scientific journal published by Nature Research. It covers the natural sciences, including physics, biology, chemistry, medicine, and earth sciences. It began publishing in 2010 and has editorial offices in London, Berlin, New York City, and Shanghai.

Oct 18, 2022

Vaccines to treat cancer possible by 2030, say BioNTech founders

Posted by in categories: biotech/medical, innovation

Vaccines that target cancer could be available before the end of the decade, according to the husband and wife team behind one of the most successful Covid vaccines of the pandemic.

Uğur Şahin and Özlem Türeci, who co-founded BioNTech, the German firm that partnered with Pfizer to manufacture a revolutionary mRNA Covid vaccine, said they had made breakthroughs that fuelled their optimism for cancer vaccines in the coming years.

Oct 18, 2022

Transient cell-in-cell formation underlies tumor relapse and resistance to immunotherapy

Posted by in category: biotech/medical

Tumors escape killing by the immune system through generating transient spatial cell-in-cell structures that are impenetrable to cytotoxic compounds including lytic granules and chemotherapy.

Oct 18, 2022

Dr. Jarah Meador, Ph.D. — Director, Open Innovation Programs — U.S. General Services Administration

Posted by in categories: biotech/medical, government, military, policy

Is Director, Open Innovation Programs, (Challenge. Gov — https://www.challenge.gov & CitizenScience. Gov — https://www.citizenscience.gov), at the U.S. General Services Administration (GSA — https://www.gsa.gov).

The GSA is an independent agency of the United States government established in 1949 to help manage and support the basic functioning of various federal agencies, supplying products and communications for U.S. government offices, providing transportation and office space to federal employees, and developing government-wide cost-minimizing policies and other management tasks.

Continue reading “Dr. Jarah Meador, Ph.D. — Director, Open Innovation Programs — U.S. General Services Administration” »

Oct 18, 2022

Role of spike in the pathogenic and antigenic behavior of SARS-CoV-2 BA.1 Omicron

Posted by in categories: biotech/medical, genetics

The recently identified, globally predominant SARS-CoV-2 Omicron variant (BA.1) is highly transmissible, even in fully vaccinated individuals, and causes attenuated disease compared with other major viral variants recognized to date1 7. The Omicron spike (S) protein, with an unusually large number of mutations, is considered the major driver of these phenotypes3,8. We generated chimeric recombinant SARS-CoV-2 encoding the S gene of Omicron in the backbone of an ancestral SARS-CoV-2 isolate and compared this virus with the naturally circulating Omicron variant. The Omicron S-bearing virus robustly escapes vaccine-induced humoral immunity, mainly due to mutations in the receptor-binding motif (RBM), yet unlike naturally occurring Omicron, efficiently replicates in cell lines and primary-like distal lung cells. In K18-hACE2 mice, while Omicron causes mild, non-fatal infection, the Omicron S-carrying virus inflicts severe disease with a mortality rate of 80%. This indicates that while the vaccine escape of Omicron is defined by mutations in S, major determinants of viral pathogenicity reside outside of S.

The authors have declared no competing interest.

Oct 18, 2022

BioNTech Founders Predict Cancer Vaccine Is Only Years Away

Posted by in categories: biotech/medical, innovation

The husband-and-wife team who co-founded BioNTech, the biotechnology company that partnered with Pfizer to develop an effective messenger-RNA (mRNA) shot against COVID-19, has predicted that a cancer vaccine could be widely available within the next decade.

“Yes, we feel that a cure for cancer, or to changing cancer patients’ lives, is in our grasp,” said Professor Ozlem Tureci during an interview on BBC’s ‘Sunday with Laura Kuenssberg’.

The cancer vaccine, which would build upon breakthroughs achieved by the scientists during the development of the COVID-19 shot, may be widely available within just eight years, said Professor Ugur Sahin.

Oct 18, 2022

Gut Could Sound Early Warning Alarm for Motor Neuron Disease

Posted by in categories: biotech/medical, neuroscience

Summary: Proteins associated with motor neuron disease, or ALS are present in the gut many years before disease pathologies can be found in the brain. A stool sample or gut biopsy could help identify the presence of MND-associated proteins years before symptoms appear.

Source: University of Aberdeen.

The same proteins thought to contribute to motor neuron disease can be found in the gut many years before any brain symptoms occur, a new study by the University of Aberdeen has found.

Oct 18, 2022

Common diabetes medication identified as a possible treatment for atrial fibrillation

Posted by in categories: biotech/medical, genetics

Cleveland Clinic researchers have identified a common diabetes medication, metformin, as a possible treatment for atrial fibrillation.

The study, published in Cell Reports Medicine, built on ongoing collaborative Cleveland Clinic research to support further investigation into metformin as a drug repurposing candidate. Researchers used advanced computation and genetic sequencing to determine that metformin’s targets overlap significantly with genes dysregulated in atrial fibrillation.

Finding drugs or procedures to treat atrial fibrillation is difficult because of potential serious side effects. There is a significant need for new treatments for atrial fibrillation as there have been no new drugs approved in more than a decade.

Oct 18, 2022

Mouse Study Reveals How to Help Speed Up The Liver’s Self-Regeneration Process

Posted by in category: biotech/medical

The liver is known for its ability to regenerate. It can completely regrow itself even after two-thirds of its mass has been surgically removed. But damage from medications, alcohol abuse, or obesity can eventually cause the liver to fail.

Currently, the only effective treatment for end-stage liver disease is transplantation.

However, there is a dearth of organs available for transplantation. Patients may have to wait from 30 days to over 5 years to receive a liver for transplant in the US. Of the over 11,600 patients on the waiting list to receive a liver transplant in 2021, only a little over 9,200 received one.

Oct 17, 2022

In a ‘tour de force,’ researchers image an entire fly brain in minute detail

Posted by in categories: biotech/medical, neuroscience

Circa 2018 face_with_colon_three


“This data set—and the opportunities it creates—are … arguably one of the most important things to have happened in neurobiology recently,” says Rachel Wilson, a neurobiologist at Harvard University who was not involved in the new work. “Anyone in the world who is interested can download the data set and determine whether any two neurons … talk to each other.”

Continue reading “In a ‘tour de force,’ researchers image an entire fly brain in minute detail” »

Page 820 of 2,683First817818819820821822823824Last